Bifogade filer
Kalender
Tid* | ||
2025-11-14 | 07:30 | Kvartalsrapport 2025-Q3 |
2025-08-22 | 07:30 | Kvartalsrapport 2025-Q2 |
2025-05-09 | 07:30 | Kvartalsrapport 2025-Q1 |
2025-04-09 | N/A | Årsstämma |
2025-03-05 | 08:00 | Bokslutskommuniké 2024 |
2024-11-15 | - | Kvartalsrapport 2024-Q3 |
2024-08-22 | - | Kvartalsrapport 2024-Q2 |
2024-05-08 | - | Kvartalsrapport 2024-Q1 |
2024-04-17 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2024-04-16 | - | Årsstämma |
2024-03-06 | - | Bokslutskommuniké 2023 |
2023-11-16 | - | Kvartalsrapport 2023-Q3 |
2023-08-23 | - | Kvartalsrapport 2023-Q2 |
2023-05-09 | - | Kvartalsrapport 2023-Q1 |
2023-03-31 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2023-03-30 | - | Årsstämma |
2023-03-02 | - | Bokslutskommuniké 2022 |
2022-11-09 | - | Kvartalsrapport 2022-Q3 |
2022-08-24 | - | Kvartalsrapport 2022-Q2 |
2022-05-09 | - | Kvartalsrapport 2022-Q1 |
2022-04-06 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2022-04-05 | - | Årsstämma |
2022-03-04 | - | Bokslutskommuniké 2021 |
2021-11-12 | - | Kvartalsrapport 2021-Q3 |
2021-08-25 | - | Kvartalsrapport 2021-Q2 |
2021-05-27 | - | Kvartalsrapport 2021-Q1 |
2021-04-21 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2021-04-20 | - | Årsstämma |
2021-03-12 | - | Bokslutskommuniké 2020 |
2020-11-11 | - | Kvartalsrapport 2020-Q3 |
2020-08-26 | - | Kvartalsrapport 2020-Q2 |
2020-06-15 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2020-06-12 | - | Årsstämma |
2020-05-14 | - | Kvartalsrapport 2020-Q1 |
2020-02-20 | - | Bokslutskommuniké 2019 |
2019-11-27 | - | Extra Bolagsstämma 2019 |
2019-11-07 | - | Kvartalsrapport 2019-Q3 |
2019-08-15 | - | Kvartalsrapport 2019-Q2 |
2019-04-25 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2019-04-24 | - | Årsstämma |
2018-04-18 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2018-04-17 | - | Årsstämma |
2017-04-26 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2017-04-25 | - | Årsstämma |
2016-04-21 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2016-04-20 | - | Årsstämma |
2015-04-24 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2015-04-23 | - | Årsstämma |
2014-04-25 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2014-04-24 | - | Årsstämma |
2013-04-18 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2013-04-17 | - | Årsstämma |
2012-04-17 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2012-04-16 | - | Årsstämma |
2011-04-27 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
2011-04-26 | - | Årsstämma |
2010-04-28 | - | X-dag ordinarie utdelning BAVA 0.00 DKK |
Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
COPENHAGEN, Denmark, August 23, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
1. | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Karen Merete Jensen | |
2. | Reason for the notification | ||
a) | Position/status | Member of the Board of Bavarian Nordic A/S (employee-elected) | |
b) | Initial notification/Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Bavarian Nordic A/S | |
b) | LEI | 2138006JCDVYIN6INP51 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Shares DK0015998017 | |
b) | Nature of the transaction | Sale | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 275.97 | 200 | ||
d) | Aggregated information
| 200 DKK 55,193.00 | |
e) | Date of the transaction | 2024-08-22 | |
f) | Place of the transaction | Nasdaq Copenhagen A/S, XCSE |
About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox vaccines, supplied to governments to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.
Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, rss@bavarian-nordic.com, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600
Company Announcement no. 26 / 2024